Evgeniya Yu. Pashkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Evgeniya Yu. Pashkova has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Aleksander Sergeevich Ametov
Russian Medical Academy of Continuing Professional Education
32 shared publications Moscow City Clinical Hospital Named After S.P. Botkin
11 shared publications- Ksenya A. Amikishieva
Russian Medical Academy of Continuous Professional Education
10 shared publications - Ivan I. Golodnikov
Endocrinology Research Centre
8 shared publications - Aleksey Vasilyevich Shabunin
Botkin Hospital; Russian Medical Academy of Continuous Professional Education
6 shared publications - Mikhail Mikhailovich Tavobilov
Botkin Hospital; Russian Medical Academy of Continuous Professional Education
6 shared publications
Latest Publications
- 5 September 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (5-6) , 45-49
Thyroidectomy as a Treatment for Complicated Thyrotoxicosis
Background . The only conservative treatment for diffuse toxic goiter currently is the use of antithyroid drugs — thiamazole and propylthiouracil. Agranulocytosis occurs in approximately 0.2–0.5% of patients, usually at the beginning of treatment with thiamazole or propylthiouracil, but may also occur later, even during repeated therapy. Mortality among patients with agranulocytosis reaches 4%. The aim of this article is to present a clinical case of a patient with a long-standing diffuse toxic goiter, as well as several relapses of thyrotoxicosis due to irregular administration of antithyroid therapy, and the development of agranulocytosis during the next course of treatment. Description of the clinical case. A detailed conservative treatment of both thyrotoxicosis and agranulocytosis is reflected. Aspects of surgical treatment and anesthetic care are discussed. Discussion . To rapidly achieve euthyroidism, both unfairly neglected methods, such as short-term inorganic iodine supplementation and modern plasmapheresis, were used. This combination of therapeutic approaches allowed for radical surgery. Conclusions . The combination of modern extracorporeal detoxification methods and inorganic iodine therapy enabled rapid achievement of euthyroidism and radical surgery in this clinical case.
- 5 September 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (5-6) , 45-49
Thyroidectomy as a Treatment for Complicated Thyrotoxicosis
Background . The only conservative treatment for diffuse toxic goiter currently is the use of antithyroid drugs — thiamazole and propylthiouracil. Agranulocytosis occurs in approximately 0.2–0.5% of patients, usually at the beginning of treatment with thiamazole or propylthiouracil, but may also occur later, even during repeated therapy. Mortality among patients with agranulocytosis reaches 4%. The aim of this article is to present a clinical case of a patient with a long-standing diffuse toxic goiter, as well as several relapses of thyrotoxicosis due to irregular administration of antithyroid therapy, and the development of agranulocytosis during the next course of treatment. Description of the clinical case. A detailed conservative treatment of both thyrotoxicosis and agranulocytosis is reflected. Aspects of surgical treatment and anesthetic care are discussed. Discussion . To rapidly achieve euthyroidism, both unfairly neglected methods, such as short-term inorganic iodine supplementation and modern plasmapheresis, were used. This combination of therapeutic approaches allowed for radical surgery. Conclusions . The combination of modern extracorporeal detoxification methods and inorganic iodine therapy enabled rapid achievement of euthyroidism and radical surgery in this clinical case.
- 26 June 2026
- Published by Bionika Media in Therapy
- Vol. 4_2026
Hypertriglyceridemia and dysglycemia: Pathogenic affinities and clinical consequences
- 26 June 2026
- Published by Bionika Media in Therapy
- Vol. 4_2026
Hypertriglyceridemia and dysglycemia: Pathogenic affinities and clinical consequences
- Open Access
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Chronic Calcific Pancreatitis and Diabetes Mellitus: Hidden Pathogenetic Mechanisms and Clinical Significance
Aim. To assess carbohydrate metabolism in patients with chronic calcific pancreatitis (CCP), analyze the relationship between endocrine and exocrine pancreatic insufficiency, and determine its clinical significance for the diagnosis and management of diabetes mellitus in this patient population. Design. A mixed retrospective and prospective comparative cohort study. Materials and methods. The study included 189 patients with confirmed CCP, comprising a prospective group (n = 51) and a retrospective group (n = 138). Carbohydrate metabolism was assessed using blood glucose levels, glycated hemoglobin, C-peptide, free insulin, glucagon, oral glucose tolerance test results, and mixed meal test results. Exocrine pancreatic function was evaluated by measuring fecal pancreatic elastase-1 (PE-1). Results. Only 31.2% of patients had normal carbohydrate metabolism, whereas 68.8% were diagnosed with prediabetes or different types of diabetes mellitus. Exocrine insufficiency of varying severity was detected in 53.3% of patients with a verified diagnosis of CCP lasting at least five years. All patients with severe exocrine insufficiency had insulin-requiring diabetes mellitus. Patients with severe PE-1 deficiency had markedly reduced insulin-secreting capacity, which was confirmed by the mixed meal test. Administration of adequate doses of pancreatic enzyme replacement therapy led to an increase in insulin requirements to levels close to physiological. Conclusion. CCP is associated with a marked decrease in both exocrine and endocrine pancreatic function. All patients with CCP require annual metabolic screening, and patients with symptoms of malabsorption should undergo fecal PE-1 assessment and correction of enzyme insufficiency.
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessChronic Calcific Pancreatitis and Diabetes Mellitus: Hidden Pathogenetic Mechanisms and Clinical Significance
Aim. To assess carbohydrate metabolism in patients with chronic calcific pancreatitis (CCP), analyze the relationship between endocrine and exocrine pancreatic insufficiency, and determine its clinical significance for the diagnosis and management of diabetes mellitus in this patient population. Design. A mixed retrospective and prospective comparative cohort study. Materials and methods. The study included 189 patients with confirmed CCP, comprising a prospective group (n = 51) and a retrospective group (n = 138). Carbohydrate metabolism was assessed using blood glucose levels, glycated hemoglobin, C-peptide, free insulin, glucagon, oral glucose tolerance test results, and mixed meal test results. Exocrine pancreatic function was evaluated by measuring fecal pancreatic elastase-1 (PE-1). Results. Only 31.2% of patients had normal carbohydrate metabolism, whereas 68.8% were diagnosed with prediabetes or different types of diabetes mellitus. Exocrine insufficiency of varying severity was detected in 53.3% of patients with a verified diagnosis of CCP lasting at least five years. All patients with severe exocrine insufficiency had insulin-requiring diabetes mellitus. Patients with severe PE-1 deficiency had markedly reduced insulin-secreting capacity, which was confirmed by the mixed meal test. Administration of adequate doses of pancreatic enzyme replacement therapy led to an increase in insulin requirements to levels close to physiological. Conclusion. CCP is associated with a marked decrease in both exocrine and endocrine pancreatic function. All patients with CCP require annual metabolic screening, and patients with symptoms of malabsorption should undergo fecal PE-1 assessment and correction of enzyme insufficiency.
- 1 January 2026
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 15 (1)
An interdisciplinary personalized approach to patients with carpal tunnel syndrome and endocrine pathology
- 1 January 2026
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 15 (1)
An interdisciplinary personalized approach to patients with carpal tunnel syndrome and endocrine pathology
- Open Access
- 24 July 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (3) , 295-304
Clinical paradox: insulinoma in a patient with type 1 diabetes mellitus
Insulinoma is a rare neuroendocrine tumor occurring from beta-cells of the pancreas. Тhe diagnosis of insulinoma may be difficult, especially in patients with concomitant diabetes mellitus. The reason for the similar clinical picture in these patients could be an incorrect scheme of hypoglycemic therapy. There is a number of cases of insulinoma in patients with type 2 diabetes mellitus described in literature. A more paradoxical clinical situation is the development of insulinoma in a patient with type 1 diabetes mellitus (T1DM). Analyzing a huge amount of literature sources, only three articles describing insulinoma in patients with T1DM were discovered. In all the described cases, the tumors turned out to be malignant. We present the first described in literature clinical case of the diagnosis and treatment of insulinoma in a patient with latent autoimmune diabetes in adults (LADA-diabetes), as well as the review of the literature on this topic. A gradual decrease in the need for exogenous insulin in combination with recurrent hypoglycemia made it possible to suspect the diagnosis, which was confirmed during a fasting test and instrumental examination of the tumor using computer tomography and endoscopic ultrasound.
- 24 July 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (3) , 295-304
Open AccessClinical paradox: insulinoma in a patient with type 1 diabetes mellitus
Insulinoma is a rare neuroendocrine tumor occurring from beta-cells of the pancreas. Тhe diagnosis of insulinoma may be difficult, especially in patients with concomitant diabetes mellitus. The reason for the similar clinical picture in these patients could be an incorrect scheme of hypoglycemic therapy. There is a number of cases of insulinoma in patients with type 2 diabetes mellitus described in literature. A more paradoxical clinical situation is the development of insulinoma in a patient with type 1 diabetes mellitus (T1DM). Analyzing a huge amount of literature sources, only three articles describing insulinoma in patients with T1DM were discovered. In all the described cases, the tumors turned out to be malignant. We present the first described in literature clinical case of the diagnosis and treatment of insulinoma in a patient with latent autoimmune diabetes in adults (LADA-diabetes), as well as the review of the literature on this topic. A gradual decrease in the need for exogenous insulin in combination with recurrent hypoglycemia made it possible to suspect the diagnosis, which was confirmed during a fasting test and instrumental examination of the tumor using computer tomography and endoscopic ultrasound.
- Open Access
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Ovarian Struma in a Patient with Recurrent Thyrotoxicosis
Aim. To present a clinical case of struma ovarii in a patient with recurrent thyrotoxicosis. Key points. In most cases, struma ovarii is an incidental finding during histological examination following adnexectomy for a detected ovarian mass. Currently, preoperative diagnosis of struma ovarii poses significant challenges, as both clinical-laboratory manifestations and ultrasonographic features are often nonspecific. Moreover, the exceptionally rare occurrence of thyroid hormone hyperproduction by struma ovarii has led to its exclusion from the diagnostic workup of thyrotoxicosis. This report describes a case of struma ovarii detected in a patient with a previously diagnosed diffuse toxic goiter and recurrent thyrotoxicosis, who presented with an ovarian mass. Conclusion. Struma ovarii is a rare form of ovarian teratoma composed predominantly of thyroid tissue and is typically benign. Due to its extreme rarity and the absence of specific clinical, radiographic, or serum markers for this teratoma, preoperative suspicion of struma ovarii prior to surgical intervention and histological examination remains exceptionally challenging. Consequently, this condition demands further in-depth research to develop reliable methods for preoperative verification, which would optimize surgical management and minimize intervention extent. Keywords: struma ovarii, ovarian teratoma, Graves’ disease, thyrotoxicosis
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessOvarian Struma in a Patient with Recurrent Thyrotoxicosis
Aim. To present a clinical case of struma ovarii in a patient with recurrent thyrotoxicosis. Key points. In most cases, struma ovarii is an incidental finding during histological examination following adnexectomy for a detected ovarian mass. Currently, preoperative diagnosis of struma ovarii poses significant challenges, as both clinical-laboratory manifestations and ultrasonographic features are often nonspecific. Moreover, the exceptionally rare occurrence of thyroid hormone hyperproduction by struma ovarii has led to its exclusion from the diagnostic workup of thyrotoxicosis. This report describes a case of struma ovarii detected in a patient with a previously diagnosed diffuse toxic goiter and recurrent thyrotoxicosis, who presented with an ovarian mass. Conclusion. Struma ovarii is a rare form of ovarian teratoma composed predominantly of thyroid tissue and is typically benign. Due to its extreme rarity and the absence of specific clinical, radiographic, or serum markers for this teratoma, preoperative suspicion of struma ovarii prior to surgical intervention and histological examination remains exceptionally challenging. Consequently, this condition demands further in-depth research to develop reliable methods for preoperative verification, which would optimize surgical management and minimize intervention extent. Keywords: struma ovarii, ovarian teratoma, Graves’ disease, thyrotoxicosis
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 14 (1)
Impact of left gastric artery embolization on metabolic health in obese patients
Влияние эмболизации левой желудочной артерии на показатели метаболического здоровья у пациентов с ожирением
- 1 January 2025
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 14 (1)
Open AccessImpact of left gastric artery embolization on metabolic health in obese patients
Влияние эмболизации левой желудочной артерии на показатели метаболического здоровья у пациентов с ожирением